Inventor · disambiguated record
Martin Lanzendoerfer
Also filed as: LANZENDOERFER MARTIN
14 granted patents·10 pending applications·214 citations·filing 2003–2019
94Inventor score
Top patents by PatentIndex Score
24 records- 0197US7501496B1Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2005·Granted Mar 10, 2009·87 cites·26 claims
- 0295US9499625B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·33 claims
- 0394US9879085B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Jan 30, 2018·10 cites·20 claims
- 0494US9663580B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted May 30, 2017·11 cites·20 claims
- 0594US9499626B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2015·Granted Nov 22, 2016·12 cites·31 claims
- 0693US9499624B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Nov 22, 2016·12 cites·15 claims
- 0793US7868141B2Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2008·Granted Jan 11, 2011·21 cites·23 claims
- 0891US10077314B1Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted Sep 18, 2018·5 cites·20 claims
- 0991US10072087B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Sep 11, 2018·5 cites·20 claims
- 1090US9102733B2Anti-OX40L antibodiesENDL JOSEPH·Filed 2010·Granted Aug 11, 2015·20 cites·17 claims
- 1189US8999327B2Antibodies against human CSF-1R and uses thereofDIMOUDIS NIKOLAOS·Filed 2010·Granted Apr 7, 2015·16 cites·10 claims
- 1288US10287358B2Antibodies against human CSF-1R and uses thereofHOFFMANN LA ROCHE·Filed 2018·Granted May 14, 2019·3 cites·20 claims
- 1371US2019300614A1Antibodies against human csf-1r and uses thereofHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1462US9724425B2Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2014·Granted Aug 8, 2017·0 cites·6 claims
- 1559US2005118169A1Antibodies against interleukin-1 receptor and uses thereofFiled 2004·Application pending·0 cites
- 1657US2009191187A1Antibodies against interleukin-1 receptor and uses thereofBARTKE ILSE·Filed 2009·Application pending·0 cites
- 1757US2008248510A1HUMAN Fc GAMMA RECEPTOR IIIBRINKMANN ULRICH·Filed 2008·Application pending·0 cites
- 1856US2013217623A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)HOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1953US2012322732A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2012·Application pending·0 cites
- 2053US2006154865A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2005·Application pending·0 cites
- 2151US2005153416A1Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereofFiled 2003·Application pending·0 cites
- 2248US2011009317A1Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)AMREIN BEAT·Filed 2010·Application pending·0 cites
- 2347US2011183354A1HUMAN Fc GAMMA RECEPTOR IIIBRINKMANN ULRICH·Filed 2011·Application pending·0 cites
- 2442US7544493B2Method for the purification of an N-terminal fragment of hepatocyte growth factorHOFFMANN LA ROCHE·Filed 2005·Granted Jun 9, 2009·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Martin Lanzendoerfer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →